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Conclusions
Hospital volume of CABG procedures did not correlate sig-
nificantly with RAMR in the clinical database collected by
the California CABG Outcomes Reporting Program during
2003–2004. Individual surgeon total CABG volume also
did not correlate with RAMR. The majority of programs
in California are low volume by accepted standards, and
most surgeons work at more than 1 hospital. We therefore
studied the relationship of surgeon volume per hospital to
RAMR.
Surgeon CABG volume per hospital appears to correlate
with RAMR. High-volume surgeons who perform a small
volume of CABG procedures in a hospital have no better
outcomes than low-volume surgeons, suggesting that system
factors are more important to outcomes than surgeon experi-
ence.
High-volume surgeons who work primarily in 1 hospital
have better outcomes than high-volume surgeons who work
in multiple hospitals. Processes of care that are associated
with these surgeons might account for this difference.
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TABLE 4. High-volume surgeons working only at high-volume sites (group A) compared with high-volume surgeons













Group A 71/74 13,901 383 437 2.76 3.14 2.70
Group B-1 (high) 89/104 16,186 485 473 3.00 2.92 3.16
Group B-2 (low) 110/226 6066 216 193 3.56 3.18 3.45
CABG, Coronary artery bypass grafting; RAMR, risk-adjusted mortality rate.
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Dr Ludwig Karl von Segesser (Lausanne, Switzerland). I wish to
congratulate Dr Carey and colleagues for providing the manuscript
and for bringing up a very important issue, which might become
even more critical if CABG numbers are decreasing in the future.
I believe that most of us are happy to learn that the high-volume
surgeon in a low-volume environment does like others in that envi-
ronment. The main concern is, of course, that if a problem occurs,
the surgeon gets most of the blame, and much less goes to the other
team members. I am wondering whether further subgroup analysis is
possible and whether there is a difference between the high-volume
generalist cardiac surgeon compared with the high-volume CABG
specialist? For the future, it might be important not to be focused
on CABG alone. I am also wondering whether the low-volume sur-
geons are treated unfavorably in the statistical analysis here. If you
have a surgeon doing 10 CABG procedures a year and he loses 1
patient, his mortality will be 10%, and if he does not lose a patient
in the second year, it will be 0%, and therefore the mean will be 5%.
Even if he loses no patient in the following 8 years, his mortality in
this analysis will be 5% compared with that of others who lose 1 of
100 patients, where the mortality will be 1%.
I have the following questions. How does a high-volume CABG
surgeon perform when he does a few procedures in another high-
volume program compared with those who do a lot in the other
high-volume program? How does a high-volume surgeon do in
CABG, valve, and other procedures compared with a high-volume
surgeon doing CABG alone in a high-volume environment, and
what about the same for a low-volume environment?
Thank you for the privilege to comment on this paper.
Dr Carey. Thank you very much for those comments. We did
not look at how the numbers would compare if those low-volume
procedures done by high-volume surgeons were done in a high-vol-
ume institution. We did not break it down. That would have been
a third dimension that got me kind of confused. Therefore we mightcic and Cardiovascular Surgery c Volume 135, Number 6 1259
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examined.
We do not have valve data or other data for the surgeons. This is
an unfortunate choice that has been made by a lot of these states.
They like to look at coronary bypass surgery because it is the high-
est-volume operation, and they tend to ignore the valves, although I
believe that they are doing some valve reporting in some of the other
states now. Therefore it will eventually happen, but we do not have it
in California at this time.
Dr Robert A. Guyton (Atlanta, Ga). I enjoyed the paper, and
this has obviously been a controversy for a long time. The Coronary
Bypass Guidelines Group looked hard at this and was unable to find
convincing evidence that volume was related to performance, partic-
ularly because it is very common to find low-volume surgeons who
are among the very best in the cohort.
The question I have is whether you were able to separate out the
patients undergoing isolated coronary bypass because about 15% or
20% of your patients undergo combined operations, presumably pa-
tients undergoing coronary valve operations. I presume that even
though only 20% of your patients are combined patients, probably
40% of the deaths are in that category. Were you able to sort that
out because that might be more meaningful in that the combined
patients might tend to be focused on a certain group of surgeons
compared with the patients undergoing isolated coronary bypass.
Dr Carey. We do not have any mortality rates for the noniso-
lated cases in this group. We just used the total CABG numbers
to break down the high- and low-volume surgeons because there
were a few surgeons who performed a lot of nonisolated CABG pro-
cedures and not very many isolated procedures. However, the risk
adjustment was only for patients undergoing isolated coronary
bypass. Therefore we have no information on that other group.
Dr Guyton. The risk-adjusted mortality data are only for the
isolated patients in your series, even though you collected the data
for the entire series? Therefore the data that you presented are
only for isolated coronary bypass?
Dr Carey. Right.
Dr Guyton. I am sorry. That was not clear. Thank you.
Dr Carey. The reason for collecting all the CABG procedures is
to try to plug the loophole of moving patients back and forth from
isolated and nonisolated procedures and thereby gaming our data.
Therefore all of those nonisolated cases were audited.
Dr R. Scott Mitchell (Stanford, Calif). Thanks a lot for the in-
formation. I think the most worrisome feature that I see when I look
at these data is the California performance compared with perfor-
mance in the 3 other states. I wonder whether you had insight into
that difference. Do you know the typical volume for cases per
surgeon in the other states that report versus California, which has
multiple programs and multiple surgeons?
Dr Carey. Well, they are higher, on average, and all of the states
pretty much have, or at least all of the bigger states have, higher
numbers of cases per program, and to some extent they have higher
numbers of procedures per surgeon. It was interesting to me to see
that the vast majority of procedures in California were actually1260 The Journal of Thoracic and Cardiovascular Surgery c Jperformed by what we defined as high-volume surgeons. These
are surgeons performing an average of 121 CABG procedures per
year, and most of them are performing a lot of other operations as
well. Therefore these are busy surgeons, and therefore the fact
that we have a higher mortality rate is kind of hard to blame on
anything related to volume. It might be related to something to do
with percutaneous coronary intervention. We reported that some
years ago at the Western—you might remember that—and we
thought that the mortality rate for CABG was related to aggressive
percutaneous coronary intervention performance. It is a little hard to
prove that. In New York there are some data to suggest that they do
not do a lot of aggressive percutaneous coronary interventions. That
has been reported by some of the people from Michigan; they looked
at that.
The data from California, or the percutaneous coronary interven-
tion data anyway, are pretty similar to those from the rest of the
country, whereas in New York they are not. Percutaneous coronary
intervention mortality in New York is almost 0%, and it is 11ˇ/2 % in
the rest of the country.
Dr Ralph J. Damiano (St Louis, Mo). I had one quick question
for you. What struck me most about your data was the tremendous
variation in results in the low-volume programs, whereas most of
your high-volume programs clustered very closely around the
same mortality. Have you looked at the variation in mortality rates
by volume of the centers; that is, could you give us an idea of the
standard deviation? If there is a wide variability, can you really ac-
cept the fact that you are taking patients at the low-volume centers
and subjecting them to potentially getting a surgeon with a good
mortality rate but also potentially getting surgeon with an extremely
high mortality rate either because of the low volume of the hospital
or the low volume of the surgeon? Is that something we can live with
as a profession?
Dr Carey. The variation from year to year is not that much. The
better performers tend to be better performers, and the worse per-
formers tend to be worse performers.
Dr Damiano. But I am just looking at your scatter plots. There
looks like a huge variation in the low-volume centers, whereas all of
your high-volume centers were clustered around the same mortality
rate.
Dr Carey. To some extent that is true, although there was one
slide in there with hospital volumes that showed there was a fair
scatter in the higher-volume hospitals. The scatter in the lower-vol-
ume hospitals is partly related to what the discussant brought up, that
one mortality makes a difference. But for the most part, there is some
consistency from year to year, even in the low-volume programs,
and that was looked at by Dr Birkmeyer, who has done a lot of
this volume-outcome work. He found that mortality in previous
years would predict mortality in future years. We are running
some statistics on that.
What was the second part of your comment?
Dr Damiano. It was just my own impression, but I do not know
whether you tried to quantify the variation by volume.
Dr Carey. We have not really looked at the details of that yet.une 2008
